FONDAPARINUX USAGE IN NON-ST-ELEVATION ACUTE CORONARY SYNDROME

FONDAPARINUX USAGE IN NON-ST-ELEVATION ACUTE CORONARY SYNDROME

Anticoagulation treatment is a vital component of acute coronary syndrome treatment. Selection of the most efficient and safe drug for the acute coronary syndrome patients without ST elevation (NSTEACS) depends on the strategy of treatment and is in fact a difficult task. Fondaparinux (Arixtra) is a...

Full description

Bibliographic Details
Main Authors:	G. V. Mardaryan, S. A. Abugov
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2015-09-01
Series:	Российский кардиологический журнал
Subjects:	acute coronary syndrome nsteacs anticoagulation pci fondaparinux enoxaparin myocardial infarction bleeding
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/253

Similar Items

Choosing between Enoxaparin and Fondaparinux for the management of patients with acute coronary syndrome: A systematic review and meta-analysis
by: Pravesh Kumar Bundhun, et al.
Published: (2017-05-01)

Comparative Evaluation of Efficacy, Safety and Haemostatic Parameters of Enoxaparin and Fondaparinux in Unstable Coronary Artery Disease
by: Sanjay Shah, et al.
Published: (2014-01-01)

THE USE OF ENOXAPARIN IN ACUTE CORONARY SYNDROME
by: E. A. Smirnova, et al.
Published: (2017-01-01)

Thromboprofilaxys With Fondaparinux vs. Enoxaparin in Hospitalized COVID-19 Patients: A Multicenter Italian Observational Study
by: Vincenzo Russo, et al.
Published: (2020-11-01)

The Emerging Role of Coronary CT in Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS)
by: Jimmy Oi Santoso, et al.
Published: (2021-09-01)

ANTICOAGULANTS IN ACUTE CORONARY SYNDROME
by: I. A. Latfullin, et al.
Published: (2016-01-01)

Custo-efetividade de fondaparinux em pacientes com Síndrome Coronariana Aguda sem supradesnivelamento do ST Cost-effectiveness of fondaparinux in patients with acute coronary syndrome without ST-segment Elevation
by: Camila Pepe, et al.
Published: (2012-07-01)

EARLY DISCONTINUATION OF FONDAPARINUX IN LOW-RISK PATIENTS HOSPITALIZED WITH NON-ST-ELEVATION ACUTE CORONARY SYNDROME: MARKERS OF HEMOSTASIS ACTIVATION AND IN-HOSPITAL OUTCOMES
by: I. S. Yavelov, et al.
Published: (2015-03-01)

Fondaparinux
by: G. Airoldi, et al.
Published: (2013-05-01)

UTILIZING ENOXAPARIN IN THE MANAGEMENT OF ACUTE CORONARY SYNDROME
by: O. V. Krikunova, et al.
Published: (2018-03-01)

Evaluation of bleeding risk in patients with renal impairment treated with Fondaparinux (Arixtra)
by: Hend H Metwali, et al.
Published: (2016-01-01)

Antitrombóticos nas síndromes coronarianas agudas: diretrizes atuais e novas evidências Antithrombotics in acute coronary syndromes: actual guidelines and new evidences
by: Luiz Eduardo Fonteles Ritt, et al.
Published: (2008-06-01)

Antithrombotic and Anti-Inflammatory Effects of Fondaparinux and Enoxaparin in Hospitalized COVID-19 Patients: The FONDENOXAVID Study
by: Cardillo G, et al.
Published: (2021-02-01)

Bleeding Predictor in ST-Elevation Myocardial Infarction Underwent Primary Percutaneous Coronary Infarction: The Indonesian (INA) Bleeding Risk Score
by: Wisnu A Widodo, et al.
Published: (2015-03-01)

AngioJet thrombectomy for the treatment of coronary artery aneurysm after failed thrombolysis in acute myocardial infarction
by: Giuseppe Ambrosio, et al.
Published: (2006-09-01)

Influence of fondaparinux versus nadroparin calcium thromboprophylaxis on clinical parameters following total knee arthroplasty
by: Zdravka Mihaljević, et al.
Published: (2016-01-01)

Corelation Between Matrix Metalloproteinase-9 (MMP-9) And Troponin-I (cTn-I) in ST- Elevation Myocardial Infarction (STEMI) and Non ST-Elevation Acute Coronary Syndrome (NSTEACS)
by: Budi Yuli Setianto, et al.
Published: (2013-06-01)

Risk factors for bleeding in patients receiving fondaparinux after colorectal cancer surgery
by: Jongsung Pak, et al.
Published: (2017-10-01)

CORONARY REPERFUSION IN SENILE PATIENTS WITH ACUTE ST ELEVATION MYOCARDIAL INFARCTION
by: E. V. Vyshlov
Published: (2016-08-01)

Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction with ST Segment-Elevation: Effect on the Severity of Ischemic Mitral Regurgitation
by: Mohammad Aly Hammad, et al.
Published: (2021-04-01)

Upper gastrointestinal bleed in a post menopausal woman due to combination of high first dose aspirin and clopidogrel prescribed for acute coronary syndrome
by: Vishal R Tandon, et al.
Published: (2015-01-01)

Implications of bleeding in acute coronary syndrome and percutaneous coronary intervention
by: Pham PT
Published: (2011-08-01)

Acute coronary syndrome with elevation of ST associated with ergotamine abuse
by: Pérez Baztarrica Gabriel E., et al.
Published: (2019-03-01)

Possibility of using dabigatran in patients with atrial fibrillation and acute coronary syndrome and PCI
by: A. D. Erlich
Published: (2019-04-01)

SYNTAX scale estimates of coronary stenosis severity and outcomes of various revascularisation strategies in patients with ST segment elevation myocardial infarction and multi-vessel coronary pathology
by: R. S. Tarasov, et al.
Published: (2013-04-01)

Successful use of fondaparinux for perioperative bridging in a patient with a mechanical heart valve and heparin-induced thrombocytopenia
by: C R Pruthvi, et al.
Published: (2019-01-01)

Corrected QT Interval Prolongations in Patients with non–ST-Elevation Acute Coronary Syndrome
by: Maryam Nabati, et al.
Published: (2018-10-01)

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
by: J.-P. Collet, et al.
Published: (2021-04-01)

The Comparison between the Outcomes of Streptokinase and Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction
Published: (2017-07-01)

Comparsion of influence of enoxaparin with unfractioned heparin on acute myocardial infarction with ST-segment elevation
by: Seyed Abdolhossein Tabatabaie, et al.
Published: (2009-12-01)

Intracoronary Versus Intravenous Administration of Eptifibatide During Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes
by: tooran makhdoumi
Published: (2020-10-01)

Acute ST-elevation myocardial infarction (STEMI) in a patient with a single coronary artery successfully treated with primary percutaneous coronary intervention
by: Ružičić Dušan, et al.
Published: (2017-01-01)

Comparative laboratory effectiveness of low molecular weight heparins in patients with acute coronary syndrome and no ST segment elevation
by: R. M. Linchak, et al.
Published: (2011-02-01)

DIELECTRIC SPECIFICS OF THE BLOOD IN UNSTABLE ANGINA: NEW ADDITIONAL TEST FOR ACUTE MYOCARDIAL ISCHEMIA DIAGNOSTICS
by: Yu. I. Grinshtein, et al.
Published: (2015-09-01)

APPLICATION OF RIVAROXABAN IN ACUTE CORONARY SYNDROME: EVIDENCE AND CURRENT GUIDELINES
by: O. V. Averkov
Published: (2016-01-01)

Differences by sex of the acute coronary syndrome without ST segment elevation at the Coronary Care Unit.
by: Ernesto del Pino Sanchez, et al.
Published: (2011-01-01)

Contribution of novel anticoagulants fondaparinux and dabigatran to venous thromboembolism prevention
by: Antonijević Nebojša, et al.
Published: (2015-01-01)

Percutaneous Coronary Intervention in a Patient with Acute Thrombosis of Saphenous Vein Graft and Patent Native Coronary Artery: Which is the Vessel to Approach?
by: Marco Ferrone, et al.
Published: (2015-09-01)

Effect of COVID-19 on acute treatment of ST-segment elevation and Non-ST-segment elevation acute coronary syndrome in northwestern Switzerland
by: Jasper Boeddinghaus, et al.
Published: (2021-02-01)

Markers of Autolysis in Acute ST Elevation Myocardial Infarction – A Comparative Analysis
by: Prabindra Maharjan, et al.
Published: (2015-06-01)

Cannot write session to /tmp/vufind_sessions/sess_csc36ifb38r6th7ujfdgpfrql4